BioSig Technologies (BSGM) Competitors $6.91 +0.21 (+3.13%) As of 06/12/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock BSGM vs. CBLL, BFLY, RXST, AVNS, EMBC, DCTH, BVS, KIDS, AXGN, and NPCEShould you be buying BioSig Technologies stock or one of its competitors? The main competitors of BioSig Technologies include CeriBell (CBLL), Butterfly Network (BFLY), RxSight (RXST), Avanos Medical (AVNS), Embecta (EMBC), Delcath Systems (DCTH), Bioventus (BVS), OrthoPediatrics (KIDS), AxoGen (AXGN), and NeuroPace (NPCE). These companies are all part of the "medical equipment" industry. BioSig Technologies vs. Its Competitors CeriBell Butterfly Network RxSight Avanos Medical Embecta Delcath Systems Bioventus OrthoPediatrics AxoGen NeuroPace CeriBell (NASDAQ:CBLL) and BioSig Technologies (NASDAQ:BSGM) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, community ranking, earnings, risk, institutional ownership, dividends and valuation. Which has higher valuation and earnings, CBLL or BSGM? CeriBell has higher revenue and earnings than BioSig Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCeriBell$71.54M9.19N/AN/AN/ABioSig Technologies$26K7,254.17-$29.04MN/AN/A Do institutionals & insiders have more ownership in CBLL or BSGM? 7.2% of BioSig Technologies shares are held by institutional investors. 20.1% of CeriBell shares are held by insiders. Comparatively, 17.0% of BioSig Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media favor CBLL or BSGM? In the previous week, BioSig Technologies had 2 more articles in the media than CeriBell. MarketBeat recorded 6 mentions for BioSig Technologies and 4 mentions for CeriBell. CeriBell's average media sentiment score of 1.20 beat BioSig Technologies' score of 0.93 indicating that CeriBell is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CeriBell 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BioSig Technologies 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer CBLL or BSGM? CeriBell currently has a consensus price target of $32.50, indicating a potential upside of 78.77%. BioSig Technologies has a consensus price target of $10.00, indicating a potential upside of 44.72%. Given CeriBell's higher possible upside, equities research analysts clearly believe CeriBell is more favorable than BioSig Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CeriBell 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00BioSig Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is CBLL or BSGM more profitable? CeriBell has a net margin of 0.00% compared to BioSig Technologies' net margin of -44,832.50%. Company Net Margins Return on Equity Return on Assets CeriBellN/A N/A N/A BioSig Technologies -44,832.50%N/A -776.49% Does the MarketBeat Community believe in CBLL or BSGM? BioSig Technologies received 95 more outperform votes than CeriBell when rated by MarketBeat users. However, 100.00% of users gave CeriBell an outperform vote while only 70.95% of users gave BioSig Technologies an outperform vote. CompanyUnderperformOutperformCeriBellOutperform Votes10100.00% Underperform VotesNo VotesBioSig TechnologiesOutperform Votes10570.95% Underperform Votes4329.05% SummaryCeriBell beats BioSig Technologies on 8 of the 12 factors compared between the two stocks. Get BioSig Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BSGM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BSGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BSGM vs. The Competition Export to ExcelMetricBioSig TechnologiesElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$188.61M$3.32B$5.61B$8.62BDividend YieldN/A1.75%5.28%4.17%P/E RatioN/A18.7727.1419.96Price / Sales7,254.17203.96411.83157.63Price / CashN/A44.0938.2534.64Price / Book-20.943.887.064.69Net Income-$29.04M$94.03M$3.23B$248.14M7 Day Performance-5.73%8.84%0.79%0.95%1 Month Performance174.21%18.26%9.71%5.74%1 Year Performance1,649.37%38.27%32.12%14.73% BioSig Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BSGMBioSig Technologies2.3171 of 5 stars$6.91+3.1%$10.00+44.7%+1,370.2%$188.61M$26K0.0050Gap UpHigh Trading VolumeCBLLCeriBell2.6989 of 5 stars$17.81-0.4%$32.50+82.5%N/A$643.71M$71.54M0.00N/APositive NewsBFLYButterfly Network2.2935 of 5 stars$2.48flat$4.00+61.3%+152.0%$613.28M$85.63M-5.39460RXSTRxSight3.2844 of 5 stars$15.30+1.7%$37.90+147.7%-75.4%$611.18M$148.31M-18.43220Positive NewsAVNSAvanos Medical1.7638 of 5 stars$12.63+1.4%N/A-38.9%$584.06M$689.20M37.154,040EMBCEmbecta4.2827 of 5 stars$9.91+1.2%$19.33+95.1%-21.5%$579.17M$1.08B9.911,900DCTHDelcath Systems3.6299 of 5 stars$15.95-2.6%$24.00+50.5%+118.1%$555.48M$53.85M-11.8160BVSBioventus2.5648 of 5 stars$6.72+0.4%$14.33+113.3%-1.0%$552.01M$567.70M-11.021,200Positive NewsKIDSOrthoPediatrics4.346 of 5 stars$21.54+1.7%$35.83+66.4%-31.0%$523.14M$212.45M-17.51200Positive NewsAXGNAxoGen2.3747 of 5 stars$10.41-4.7%$22.20+113.3%+24.6%$474.11M$194.52M-32.53450High Trading VolumeNPCENeuroPace3.7631 of 5 stars$12.93-1.7%$15.50+19.9%+61.6%$431.31M$84.31M-12.93170Trending NewsAnalyst Revision Related Companies and Tools Related Companies CeriBell Competitors Butterfly Network Competitors RxSight Competitors Avanos Medical Competitors Embecta Competitors Delcath Systems Competitors Bioventus Competitors OrthoPediatrics Competitors AxoGen Competitors NeuroPace Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BSGM) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioSig Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioSig Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
